the CHR-P construct for detecting individuals at risk of psychosis. At the same time, the symposium suggests specific and differential strategies for overcoming these challenges in secondary mental health care, primary care, or the community. The first speaker (Dr. Shah) will discuss the relevance of the CHR-P construct for identifying individuals at risk for psychosis. Dr. Shah found that over half of the first episode cases in a catchment area had experienced CHR-P like features prior to their illness onset, while a substantial minority of first episode cases had not. This indicates that not all the first episode cases did pass through a CHR-P like stage, thereby providing an initial estimate of what proportion of first episode cases could be prevented through interventions at the CHR-P stage. The second speaker (Dr. Fusar-Poli) will discuss the effectiveness of current CHR-P detection strategies in secondary mental health care. Dr. Fusar-Poli found that only a tiny minority (5%) of first episode cases accessing secondary mental health were detected by the local CHR-P service that had been fully established in the Trust. This study developed and validated an individualised risk calculator that can improve the detection of individuals at risk of psychosis in secondary mental health care. The third speaker (Dr. Perez) will discuss how to improve detection of individuals at risk for psychosis within primary care. Dr. Perez will present a cluster-randomised controlled trial assessing whether increased specific liaison with primary care improves the clinical effectiveness and cost-effectiveness of detection of people at high risk of developing a first psychotic illness. This study showed that intensive outreach to improve liaison with primary care is clinically and cost effective for improving the detection of at risk cases. The fourth speaker (Dr. Calkins) will discuss the importance of investigating psychosis risk as a dynamic developmental process. Dr. Calkins will present a neurodevelopment prospective study evaluating subclinical symptoms in the community. This study showed that an integrated and multidimensional evaluation of youths with early psychotic-like experiences can enrich our ability to detect individuals at risk of psychosis in the general public. These findings will be then appraised and critically integrated by the discussant, prof. Craig Morgan. 
DO ALL INDIVIDUALS WITH A FEP PASS THROUGH AN EARLIER CHR-P STATE? IMPLICATIONS FOR CLINICAL STAGING, EARLY DETECTION AND PHASE-SPECIFIC INTERVENTIONS
Jai
McGill University
Background: The CHR-P syndrome has attracted much attention as a potentially important stage for early intervention aimed at preventing or delaying the onset of psychosis. Knowledge regarding the transition from CHR-P to FEP has been widely described and disseminated, but a major (untested) assumption permeates this literature: that most or all patients with a FEP actually experienced an earlier CHR-P state. Examining this assumption will provide crucial information regarding the potential utility of public mental health efforts such as early case identification and prevention directed at the CHR-P stage. Methods: Semistructured interviews of 351 patients and families with the Circumstances of Onset and Relapse Schedule were supplemented by chart reviews in a catchment area-based sample of FEP patients in Montréal, Canada. Retrospective information was extracted regarding baseline sociodemographic variables, psychiatric and behavioral changes, and helpseeking behavior up to the point of intake in the FEP service. Experts (N=30) working in FEP and CHR settings identified which of 27 early signs and symptoms in the Topography of Psychotic Episode instrument constituted sub-threshold psychotic symptoms if they appeared prior to a syndromal-level psychotic episode. Individuals were then followed within the FEP service for up to 2 years in order to record a range of symptomatic (positive and negative symptoms, depression and anxiety) and functional (global functioning, social and occupational functioning) outcomes. Results: While most clients (between 50-68%) experienced at least one early sub-threshold psychotic symptom prior to their FEP, a substantial minority recalled no CHR-P symptoms en route to psychosis. At entry to FEP services, there were no differences in sociodemographic, cognitive, or functional variables between youth who had experienced a CHR-P state versus those who had not. Youth with a CHR-P profile had significantly longer durations between psychosis onset and making the decision to seek help (median 7.7 weeks versus 3.7 weeks), as well as the total length of the prodrome leading up to psychosis (median 36.4 weeks versus 15.0 weeks). These subgroups also differed in key symptomatic and functional outcomes, with those who passed through CHR-P states en route to FEP having significantly higher depressive and anxiety symptoms at baseline, more positive and negative psychotic symptoms at 1 year, and lower functioning for at least 1 year after the initiation of FEP treatment. Discussion: A substantial minority of FEP cases did not recall a CHR-P state, suggesting that a wide range of psychopathology precedes FEP. Nonetheless, our estimates indicate that over 50% of FEP cases could still be prevented through optimal interventions targeting the CHR-P phase. This adds a novel component to previous arguments regarding the feasibility and relevance of the CHR-P construct for FEP, and underscores the importance of early case identification for this vulnerable population. Implications of these findings for contemporary clinical staging models, prevention and intervention efforts will be discussed. 
IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN

